Effect of pioglitazone on hypoxia/reoxygenation injury and protein kinase C expression in neonatal rat cardiomyocytes / 南方医科大学学报
Journal of Southern Medical University
; (12): 1819-1823, 2011.
Article
in Zh
| WPRIM
| ID: wpr-333804
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the effect of pioglitazone on hypoxia/reoxygenation injury and the expression of protein kinase C (PKC) in neonatal rat cardiomyocytes.</p><p><b>METHODS</b>Neonatal Sprague-Dawley rat cardiomyocytes in primary culture were treated with pioglitazone or GW9662 for 24 h prior to hypoxia/reoxygenation injury. Cardiomyocyte apoptosis was evaluated with Hoechst33258 staining and the expression of PKC was detected using Western blotting.</p><p><b>RESULTS</b>In the early stage of hypoxia/reoxygenation injury, the apoptosis rates of the cardiomyocytes increased significantly from (0.20∓0.03)% of the control level to (12.22∓1.45)% (P<0.05). Pretreatment with pioglitazone significantly lowered the apoptosis rate of the cardiomyocytes with hypoxia/reoxygenation injury to (8.32∓0.89)%, and this effect was antagonized by GW9662, a specific blocker of peroxisome proliferators activated receptors γ (PPARγ). Pioglitazone did not cause increased expression of PKC in the cardiomyocytes.</p><p><b>CONCLUSION</b>Pioglitazone can ameliorate neonatal rat cardiomyocyte injury induced by hypoxia/reoxygenation partially by activating PPARγ and does not increase the expression of PKC in the cells.</p>
Full text:
1
Index:
WPRIM
Main subject:
Pathology
/
Pharmacology
/
Physiology
/
Protein Kinase C
/
Myocardial Reperfusion Injury
/
Potassium Channels
/
Cell Hypoxia
/
Rats, Sprague-Dawley
/
Apoptosis
/
Ischemic Preconditioning, Myocardial
Limits:
Animals
Language:
Zh
Journal:
Journal of Southern Medical University
Year:
2011
Type:
Article